Pharm 2 Farm Update

RNS Number : 7268I
Remote Monitored Systems PLC
15 December 2020
 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

15 December 2020

Remote Monitored Systems plc ("RMS" or the "Company")

Pharm 2 Farm Update

Remote Monitored Systems plc, announces the following update in respect of its wholly owned subsidiary, Pharm 2 Farm Limited ("P2F").

Certification of new viricidal mask

The Company has received a preliminary update in relation to the certification of P2F's new viricidal mask.

Three batches of prototype masks were produced with all three required to be certified to standard EN14683. The initial test is a preliminary breathability test.

One mask (a four ply mask with the anti-viral layer) passed this breathability test, and 2 masks failed (five ply masks with the antiviral layer) and require modification.

The Company will provide further updates as appropriate.

 

- ENDS -

 

ENQUIRIES :

Remote Monitored Systems plc

John Richardson (Executive Director)  +44 7751 118916

 

SP Angel Corporate Finance LLP                                                               +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

Peterhouse Corporate Finance   +44 20 7469 0930

Joint Broker

Lucy Williams

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAFASFLDEFFA
UK 100

Latest directors dealings